News
Explore the Latest Advancements and Updates.
New Publication Supports the Role of SeptiCyte® RAPID To Improve Infection Diagnosis in Post Surgery and Trauma Patients
Immunexpress Presenting at the Society of Critical Care Medicine (SCCM) 2026 Critical Care Congress Showing SeptiCyte RAPID® High Correlation with Blood Culture Positive Sepsis Patients
Immunexpress Announces Publication Demonstrating SeptiCyte RAPID® Utility for Differentiating Infection from Sterile Inflammation in Readmitted Bone Marrow Transplant Patients with Febrile Neutropaenia
Immunexpress Announces Publication Showing SeptiCyte RAPID® Identifies Septic Patients Most Likely to Have Positive Blood Cultures
Immunexpress’ Sepsis Test Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA) for Paediatric Patients Suspected of Sepsis
2 New Published Studies Highlight SeptiCyte RAPID’s Strong Performance and Clinical Utility in Post Cardiac Surgery Patients
Study Published in the Journal Infection Demonstrates Clinical Utility of SeptiCyte® RAPID to Diagnose Sepsis in Critically Ill Patients with Hospital Acquired Infections
Rollie Carlson Discusses Host Response Testing Gains Attention in Sepsis Diagnosis and Antibiotic Stewardship
If you are a member of the media, please contact:
David Schull
Russo Partners, LLC
david.schull@russopartnersllc.com
Maddie Stabinski
Russo Partners, LLC
madeline.stabinski@russopartnersllc.com